# The PK/PD Study of Multiple Dose of SHR3824 in Healthy Volunteers

> **NCT02361138** · PHASE1 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 48 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** SHR3824
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02361138
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2015-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02361138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02361138, "The PK/PD Study of Multiple Dose of SHR3824 in Healthy Volunteers". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT02361138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*